Jack Kraeutler, CEO of Meridian Bioscience, said: “The effective global distribution of our rapid tests for infectious disease is one of Meridian’s key strategies. By working closely with the ideal partner, Somagen Diagnostics, the Canadian market provides both of our companies with many opportunities for accelerated long-term growth.”
Kevin Blackburn, president of Somagen Diagnostics, said: “Somagen is very excited to add the Meridian Bioscience family of products to its portfolio in Canada and looks forward to serving all of the needs in the microbiology and infectious disease testing area of the laboratory.”